Skip to main content


Weitere Artikel dieser Ausgabe durch Wischen aufrufen

07.07.2021 | case report Open Access

Decision making in hematology—chronic myeloid leukemia

memo - Magazine of European Medical Oncology
Prim. Univ.-Prof. Dr. Andreas L. Petzer
Wichtige Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Chronic myeloid leukemia is nowadays associated with a good prognosis and an excellent life expectancy. However, certain levels of responses have to be achieved with the various available tyrosine kinase inhibitors at certain time points during the treatment otherwise adequate diagnostic and therapeutic actions have to be initiated. This paper will focus on these issues.

Unsere Produktempfehlungen

Abo für kostenpflichtige Inhalte

Über diesen Artikel